These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

195 related articles for article (PubMed ID: 30670791)

  • 21. Understanding the Efficiency of Splenic Hemangiosarcoma Diagnosis Using Monte Carlo Simulations.
    Herman EJ; Stern AW; Fox RJ; Dark MJ
    Vet Pathol; 2019 Nov; 56(6):856-859. PubMed ID: 31422751
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A retrospective analysis of chemotherapy switch suggests improved outcome in surgically removed, biologically aggressive canine haemangiosarcoma.
    Finotello R; Henriques J; Sabattini S; Stefanello D; Felisberto R; Pizzoni S; Ferrari R; Marconato L
    Vet Comp Oncol; 2017 Jun; 15(2):493-503. PubMed ID: 26792231
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Adjuvant Doxorubicin with or without Metronomic Cyclophosphamide for Canine Splenic Hemangiosarcoma.
    Matsuyama A; Poirier VJ; Mantovani F; Foster RA; Mutsaers AJ
    J Am Anim Hosp Assoc; 2017; 53(6):304-312. PubMed ID: 28892429
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Canine visceral hemangiosarcoma treated with surgery alone or surgery and doxorubicin: 37 cases (2005-2014).
    Batschinski K; Nobre A; Vargas-Mendez E; Tedardi MV; Cirillo J; Cestari G; Ubukata R; Dagli MLZ
    Can Vet J; 2018 Sep; 59(9):967-972. PubMed ID: 30197439
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Canine hemangiosarcoma treated with standard chemotherapy and minocycline.
    Sorenmo K; Duda L; Barber L; Cronin K; Sammarco C; Usborne A; Goldschmidt M; Shofer F
    J Vet Intern Med; 2000; 14(4):395-8. PubMed ID: 10935889
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Continuous low-dose oral chemotherapy for adjuvant therapy of splenic hemangiosarcoma in dogs.
    Lana S; U'ren L; Plaza S; Elmslie R; Gustafson D; Morley P; Dow S
    J Vet Intern Med; 2007; 21(4):764-9. PubMed ID: 17708397
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant anthracycline-based vs metronomic chemotherapy vs no medical treatment for dogs with metastatic splenic hemangiosarcoma: A multi-institutional retrospective study of the Italian Society of Veterinary Oncology.
    Marconato L; Chalfon C; Finotello R; Polton G; Vasconi ME; Annoni M; Stefanello D; Mesto P; Capitani O; Agnoli C; Amati M; Sabattini S
    Vet Comp Oncol; 2019 Dec; 17(4):537-544. PubMed ID: 31251441
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Surgery and doxorubicin in dogs with hemangiosarcoma.
    Ogilvie GK; Powers BE; Mallinckrodt CH; Withrow SJ
    J Vet Intern Med; 1996; 10(6):379-84. PubMed ID: 8947871
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prospective study of successful autologous dendritic cell therapy in dogs with splenic stage II hemangiosarcoma.
    Spiller V; Vetter M; Dettmer-Richardt C; Grammel T
    Vet J; 2024 Jul; 306():106196. PubMed ID: 39004264
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical features and prognosis of retroperitoneal hemangiosarcoma in dogs with surgical resection with or without adjuvant doxorubicin.
    Ichimata M; Toshima A; Matsuyama F; Fukazawa E; Harada K; Katayama R; Kagawa Y; Yamagami T; Kobayashi T
    J Vet Med Sci; 2023 Nov; 85(11):1231-1236. PubMed ID: 37853623
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Canine hemangiosarcoma: retrospective analysis of 104 cases.
    Brown NO; Patnaik AK; MacEwen EG
    J Am Vet Med Assoc; 1985 Jan; 186(1):56-8. PubMed ID: 4038395
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Development and validation of a hemangiosarcoma likelihood prediction model in dogs presenting with spontaneous hemoabdomen: The HeLP score.
    Schick AR; Hayes GM; Singh A; Mathews KG; Higginbotham ML; Sherwood JM
    J Vet Emerg Crit Care (San Antonio); 2019 May; 29(3):239-245. PubMed ID: 30994972
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Survival time of dogs with splenic hemangiosarcoma treated by splenectomy with or without adjuvant chemotherapy: 208 cases (2001-2012).
    Wendelburg KM; Price LL; Burgess KE; Lyons JA; Lew FH; Berg J
    J Am Vet Med Assoc; 2015 Aug; 247(4):393-403. PubMed ID: 26225611
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prognosis for dogs with stage I or II splenic hemangiosarcoma treated by splenectomy alone: 32 cases (1991-1993).
    Wood CA; Moore AS; Gliatto JM; Ablin LA; Berg RJ; Rand WM
    J Am Anim Hosp Assoc; 1998; 34(5):417-21. PubMed ID: 9728473
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integration of autologous dendritic cell-based immunotherapy in the primary treatment for patients with newly diagnosed glioblastoma multiforme: a pilot study.
    Ardon H; Van Gool S; Lopes IS; Maes W; Sciot R; Wilms G; Demaerel P; Bijttebier P; Claes L; Goffin J; Van Calenbergh F; De Vleeschouwer S
    J Neurooncol; 2010 Sep; 99(2):261-72. PubMed ID: 20146084
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Chemotherapy of canine hemangiosarcoma with doxorubicin and cyclophosphamide.
    Sorenmo KU; Jeglum KA; Helfand SC
    J Vet Intern Med; 1993; 7(6):370-6. PubMed ID: 8114034
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Human Flt3L generates dendritic cells from canine peripheral blood precursors: implications for a dog glioma clinical trial.
    Xiong W; Candolfi M; Liu C; Muhammad AK; Yagiz K; Puntel M; Moore PF; Avalos J; Young JD; Khan D; Donelson R; Pluhar GE; Ohlfest JR; Wawrowsky K; Lowenstein PR; Castro MG
    PLoS One; 2010 Jun; 5(6):e11074. PubMed ID: 20552015
    [TBL] [Abstract][Full Text] [Related]  

  • 38. In vitro effects of doxorubicin and tetrathiomolybdate on canine hemangiosarcoma cells.
    Sloan CQ; Rodriguez CO
    Am J Vet Res; 2018 Feb; 79(2):219-225. PubMed ID: 29359968
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Safety Evaluation of Autologous Tissue Vaccine Cancer Immunotherapy in a Canine Model.
    Crossley RA; Matz A; Dew T; Kalinauskas A; Faucette N; Poff B; Silbart LK; Suckow MA
    Anticancer Res; 2019 Apr; 39(4):1699-1703. PubMed ID: 30952708
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An allogeneic hybrid-cell fusion vaccine against canine mammary cancer.
    Bird RC; Deinnocentes P; Lenz S; Thacker EE; Curiel DT; Smith BF
    Vet Immunol Immunopathol; 2008 Jun; 123(3-4):289-304. PubMed ID: 18423623
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.